Cited by 252Drug Transport and Resistance MechanismsBarrier Structure and Function StudiesPharmacogenetics and Drug Metabolism

The DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index.

Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders

Open access

Qosa, Hisham, Miller, David S., Pasinelli, Piera, Trotti, Davide·2015·Brain Research

DOI 10.1016/j.brainres.2015.07.005PMC PMC4681613

Open this paper in CoChat — free account

Abstract

The strength of the blood-brain barrier (BBB) in providing protection to the central nervous system from exposure to circulating chemicals is maintained by tight junctions between endothelial cells and by a broad range of transporter proteins that regulate exchange between CNS and blood. The most important transporters that restrict the permeability of large number of toxins as well as therapeutic agents are the ABC transporters. Among them, P-gp, BCRP, MRP1 and MRP2 are the utmost studied. These efflux transporters are neuroprotective, limiting the brain entry of neurotoxins; however, they could also restrict the entry of many therapeutics and contribute to CNS pharmacoresistance. Characterization of several regulatory pathways that govern expression and activity of ABC efflux transporters in the endothelium of brain capillaries have led to an emerging consensus that these processes are complex and contain several cellular and molecular elements. Alterations in ABC efflux transporters expression and/or activity occur in several neurological diseases. Here, we review the signaling pathways that regulate expression and transport activity of P-gp, BCRP, MRP1 and MRP2 as well as how their expression/activity changes in neurological diseases. This article is part of a Special Issue entitled SI: Neuroprotection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2015.07.005

Cites

214 of 214 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders(DSM)
Leong, F. T. L. (2008) · Sage eBooks · doi:10.4135/9781412963978.n182 · Cited by 10,861
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Parkinson's disease
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,276

Flagged first, then by citations

Show all 215 references

1 of the 215 references couldn’t be matched to a known paper.

Sorted by citations

Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
Neuroimmune Axes of the Blood–Brain Barriers and Blood–Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions
Erickson, M. A., & Banks, W. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014647 · Cited by 398
The blood–brain barrier in psychosis
Pollak, T. A., Drndarski, S., Stone, J. M., David, A. S., McGuire, P. K., & Abbott, N. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30293-6 · Cited by 311
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders
Correia, A. D. A., Monteiro, A. R., Silva, R., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114485 · Cited by 219
Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood–brain barrier
Hladky, S. B., & Barrand, M. A. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0113-6 · Cited by 206
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Li, J., Zheng, M., Shimoni, O., Banks, W. A., Bush, A. I., Gamble, J. R., & Shi, B. (2021) · Advanced Science · doi:10.1002/advs.202101090 · Cited by 202
Prefrontal white matter pathology in air pollution exposed Mexico City young urbanites and their potential impact on neurovascular unit dysfunction and the development of Alzheimer's disease
Calderón‐Garcidueñas, L., Reynoso-Robles, R., Martínez, J. V., Chew, A. G. M., Pérez-Guillé, B., Mukherjee, P. S., Torres‐Jardón, R., Perry, G. L., & González-Maciel, A. (2016) · Environmental Research · doi:10.1016/j.envres.2015.12.031 · Cited by 176
Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson's Disease
Ren, T., Gao, Y., Qiu, Y., Jiang, S., Zhang, Q., Zhang, J., Wang, L., Zhang, Y., Wang, L., & Nie, K. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00137 · Cited by 173
Blood-Brain Barrier Damage in Ischemic Stroke and Its Regulation by Endothelial Mechanotransduction
Nian, K., Harding, I. C., Herman, I. M., & Ebong, E. E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.605398 · Cited by 176
Recent expansions of novel strategies towards the drug targeting into the brain
Alexander, A., Agrawal, M., Uddin, A. N. M. S., Siddique, S., Shehata, A. M., Shaker, M. A., Rahman, S. A. U., Abdul, M. I. M., & Shaker, M. A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s210876 · Cited by 165
Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer’s disease
Rad, S. K., Arya, A., Karimian, H., Madhavan, P., Rizwan, F., Koshy, S., & Prabhu, G. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s173970 · Cited by 167
Review: The blood-brain barrier; protecting the developing fetal brain
Goasdoué, K., Miller, S. M., Colditz, P. B., & Bjorkman, S. T. (2016) · Placenta · doi:10.1016/j.placenta.2016.12.005 · Cited by 161
Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders
Gil-Martins, E., Barbosa, D. J., Silva, V., Remião, F., & Silva, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107554 · Cited by 152
Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer’s Disease, Parkinson’s Disease, and Intracerebral Hemorrhage
Farr, A. C., & Xiong, M. P. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00474 · Cited by 154
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
Saunders, N. R., Habgood, M. D., Møllgård, K., & Dziegielewska, K. M. (2016) · F1000Research · doi:10.12688/f1000research.7378.1 · Cited by 143
Leaky brain in neurological and psychiatric disorders: Drivers and consequences
Morris, G., Fernandes, B. S., Puri, B. K., Walker, A. J., Carvalho, A. F., & Berk, M. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418796955 · Cited by 145
Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview
Musumeci, T., Bonaccorso, A., & Puglisi, G. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030118 · Cited by 137
Perspectives on Dual Targeting Delivery Systems for Brain Tumors
Gao, H. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9687-4 · Cited by 126
Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules
Harilal, S., Jose, J., Parambi, D. G. T., Kumar, R., Unnikrishnan, M. K., Uddin, M. S., Mathew, G. E., Pratap, R., Marathakam, A., & Mathew, B. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.018 · Cited by 127
Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain
Chaves, C., Remião, F., Cisternino, S., & Declèves, X. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170504095823 · Cited by 114
ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery
Schulz, J., Hartz, A. M. S., & Bauer, B. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000025 · Cited by 118
Waste Clearance in the Brain
Kaur, J., Fahmy, L. M., Davoodi‐Bojd, E., Zhang, L., Ding, G., Hu, J., Zhang, Z., Chopp, M., & Jiang, Q. (2021) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2021.665803 · Cited by 108
Inflammatory stress induced by a combination of cytokines (IL-6, IL-17, TNF-α) leads to a loss of integrity on bEnd.3 endothelial cells in vitro BBB model
Voirin, A.-C., Perek, N., & Roche, F. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146647 · Cited by 99
Role of ATP-binding cassette transporters in cancer initiation and progression
Nobili, S., Lapucci, A., Landini, I., Coronnello, M., Roviello, G., & Mini, E. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.006 · Cited by 101
Regulation of P-Glycoprotein in the Brain
Chai, A. B., Callaghan, R., & Gelissen, I. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314667 · Cited by 108
P‐glycoprotein: a role in the export of amyloid‐β in Alzheimer's disease?
Chai, A. B., Leung, G. K. F., Callaghan, R., & Gelissen, I. C. (2019) · FEBS Journal · doi:10.1111/febs.15148 · Cited by 100
ABC Transporters Are Key Players in Alzheimer’s Disease
Pereira, C. D., Martins, F., Wiltfang, J., Silva, O. A. B. D. C. E., & Rebelo, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170639 · Cited by 94
Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery
Oikari, L. E., Pandit, R., Stewart, R., Cuní‐López, C., Quek, H., Sutharsan, R., Rantanen, L. M., Oksanen, M., Lehtonen, Š., de Boer, C. M., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.011 · Cited by 87
Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform
Pinto, M., Silva, V., Barreiro, S., Silva, R. V. D. S., Remião, F., Borges, F., & Fernandes, C. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101658 · Cited by 97
Mitochondrial oxidative stress in brain microvascular endothelial cells: Triggering blood-brain barrier disruption
Wang, Y., Wu, J., Wang, J., He, L., Lai, H., Zhang, T., Wang, X., & Li, W. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.01.007 · Cited by 86
In vivo methods for imaging blood–brain barrier function and dysfunction
Harris, W. J., Asselin, M., Hinz, R., Parkes, L. M., Allan, S. M., Schießl, I., Boutin, H., & Dickie, B. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05997-1 · Cited by 91
ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches
Leandro, K., Bicker, J., Alves, G., Falcão, A. C., & Fortuna, A. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.04.031 · Cited by 87
The neurogliovascular unit in hepatic encephalopathy
Claeys, W., Hoecke, L. V., Lefere, S., Geerts, A. M., Verhelst, X., Vlierberghe, H. V., Degroote, H., Devisscher, L., Vandenbroucke, R. E., & Steenkiste, C. V. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100352 · Cited by 86
Selective protection of normal cells from chemotherapy, while killing drug-resistant cancer cells
Blagosklonny, M. V. (2023) · Oncotarget · doi:10.18632/oncotarget.28382 · Cited by 83
Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy
Wang, L., Shi, Y., Jiang, J., Li, C., Zhang, H., Zhang, X., Jiang, T., Wang, L., Wang, Y., & Feng, L. (2022) · Small · doi:10.1002/smll.202203678 · Cited by 71
Cerebral Vascular Toxicity of Antiretroviral Therapy
Bertrand, L., Velichkovska, M., & Toborek, M. J. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09858-x · Cited by 81
Pesticides at brain borders: Impact on the blood-brain barrier, neuroinflammation, and neurological risk trajectories
Cresto, N., Forner-Piquer, I., Baig, A. H., Chatterjee, M., Perroy, J., Goracci, J., & Marchi, N. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.138251 · Cited by 77
The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer’s Disease
Behl, T., Kaur, I., Sehgal, A., Kumar, A., Uddin, M. S., & BUNGAU, S. G. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02211-x · Cited by 78
Evolving new-age strategies to transport therapeutics across the blood-brain-barrier
Choudhari, M., Hejmady, S., Narayan Saha, R., Damle, S., Singhvi, G., Alexander, A., Kesharwani, P., & Kumar Dubey, S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120351 · Cited by 74
Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium
Brouwer, K. L. R., Evers, R., Hayden, E. R., Hu, S., Li, C. Y., zu Schwabedissen, H. E. M., Neuhoff, S., Oswald, S., Piquette‐Miller, M., Saran, C., et al. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2605 · Cited by 76
The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model
Katt, M. E., Mayo, L. N., Ellis, S., Mahairaki, V., Rothstein, J. D., Cheng, L., & Searson, P. C. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0139-4 · Cited by 69
Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
Tang, L., Feng, Y., Gao, S., Mu, Q., & Liu, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.786700 · Cited by 73
Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P‐Glycoprotein) in endothelial cells of the blood–brain barrier in mutant superoxide dismutase 1‐linked amyotrophic lateral sclerosis
Qosa, H., Lichter, J., Sarlo, M., Markandaiah, S. S., McAvoy, K., Richard, J., Jablonski, M., Maragakis, N. J., Pasinelli, P., & Trotti, D. (2016) · Glia · doi:10.1002/glia.23003 · Cited by 70
Self-citation
The restorative role of annexin A1 at the blood–brain barrier
McArthur, S., Loiola, R. A., Maggioli, E., Errede, M., Virgintino, D., & Solito, E. (2016) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0043-0 · Cited by 73
Blood–Brain Barrier Disruption and Its Involvement in Neurodevelopmental and Neurodegenerative Disorders
Aragón-González, A., Shaw, P. J., & Ferraiuolo, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315271 · Cited by 73
Solute Carriers in the Blood–Brain Barier: Safety in Abundance
Nałęcz, K. A. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2030-x · Cited by 69
Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors
Triarico, S., Maurizi, P., Mastrangelo, S., Attinà, G., Capozza, M. A., & Ruggiero, A. (2019) · Cancers · doi:10.3390/cancers11060824 · Cited by 67
Brain barriers and functional interfaces with sequential appearance of ABC efflux transporters during human development
Møllgård, K., Dzięgielewska, K. M., Holst, C. B., Habgood, M. D., & Saunders, N. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-11596-0 · Cited by 66
Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles
Poustforoosh, A., Nematollahi, M. H., Hashemipour, H., & Pardakhty, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.015 · Cited by 62
Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer’s disease and strategies for treatment
Chaves, J. C. S., Dando, S. J., White, A. R., & Oikari, L. E. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166967 · Cited by 62
Intranasal administration of vitamin D attenuates blood–brain barrier disruption through endogenous upregulation of osteopontin and activation of CD44/P-gp glycosylation signaling after subarachnoid hemorrhage in rats
Enkhjargal, B., McBride, D. W., Manaenko, A., Reis, C., Sakai, Y., Tang, J., & Zhang, J. H. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16671147 · Cited by 62
Pathways of protein and lipid receptor-mediated transcytosis in drug delivery
Thuenauer, R., Müller, S. K., & Römer, W. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1220364 · Cited by 61
Structure of the Blood Brain Barrier and its Role in the Transporters for the Movement of Substrates across the Barriers
Ankul Singh, S., & Vellapandian, C. (2023) · Current Drug Metabolism · doi:10.2174/1389200224666230608110349 · Cited by 60
Neural Progenitor Cell-Derived Extracellular Vesicles Enhance Blood-Brain Barrier Integrity by NF-κB (Nuclear Factor-κB)-Dependent Regulation of ABCB1 (ATP-Binding Cassette Transporter B1) in Stroke Mice
Zhang, L., Graf, I., Kuang, Y., Zheng, X., Haupt, M., Majid, A., Kılıç, E., Hermann, D. M., Psychogios, M., Weber, M. S., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315031 · Cited by 56
Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier
Yan, L., Moriarty, R. A., & Stroka, K. M. (2021) · Theranostics · doi:10.7150/thno.63195 · Cited by 58
Antiretroviral Treatment with Efavirenz Disrupts the Blood-Brain Barrier Integrity and Increases Stroke Severity
Bertrand, L., Dygert, L., & Toborek, M. J. (2016) · Scientific Reports · doi:10.1038/srep39738 · Cited by 57
Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis
Mohamed, L. A., Markandaiah, S. S., Bonanno, S., Pasinelli, P., & Trotti, D. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.04.002 · Cited by 52
Self-citation
Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma
Mokarram, N., Case, A. G., Hossainy, N. N., Lyon, J. G., MacDonald, T. J., & Bellamkonda, R. V. (2025) · Communications Materials · doi:10.1038/s43246-024-00721-y · Cited by 54
Recent Advancements in Liposome-Targeting Strategies for the Treatment of Gliomas: A Systematic Review
Li, J., Tan, T., Zhao, L., Liu, M., You, Y., Zeng, Y., Chen, D., Xie, T., Zhang, L., Fu, C., et al. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00705 · Cited by 51
Heterocellular spheroids of the neurovascular blood-brain barrier as a platform for personalized nanoneuromedicine
Kumarasamy, M., & Sosnik, A. (2021) · iScience · doi:10.1016/j.isci.2021.102183 · Cited by 52
Involvement of UDP-Glucuronosyltransferases and Sulfotransferases in the Excretion and Tissue Distribution of Resveratrol in Mice
Böhmdorfer, M., Szakmary, A., Schiestl, R. H., Vaquero, J., Riha, J., Brenner, S., Thalhammer, T., Szekeres, T., & Jäger, W. R. (2017) · Nutrients · doi:10.3390/nu9121347 · Cited by 49
ATP-binding cassette (ABC) drug transporters in the developing blood–brain barrier: role in fetal brain protection
Eng, M. E., Império, G. E., Bloise, E., & Matthews, S. G. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04432-w · Cited by 49
Effect of Disease Pathologies on Transporter Expression and Function
Atilano‐Roque, A., Roda, G. F., Fogueri, U., Kiser, J. J., & Joy, M. S. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.768 · Cited by 45
Efflux proteins at the blood–brain barrier: review and bioinformatics analysis
Saidijam, M., Dermani, F. K., Sohrabi, S., & Patching, S. G. (2017) · Xenobiotica · doi:10.1080/00498254.2017.1328148 · Cited by 48
Effect of GenX on P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance-Associated Protein 2 at the Blood-Brain Barrier
Cannon, R. E., Richards, A. C., Trexler, A. W., Juberg, C. T., Sinha, B., Knudsen, G. A., & Birnbaum, L. S. (2020) · Environmental Health Perspectives · doi:10.1289/ehp5884 · Cited by 43
Predictors of Pharmaco-Resistance in Patients with Post-Stroke Epilepsy
Lattanzi, S., Rinaldi, C., Cagnetti, C., Foschi, N., Norata, D., Broggi, S., Rocchi, C., & Silvestrini, M. (2021) · Brain Sciences · doi:10.3390/brainsci11040418 · Cited by 43
Metabolite transport across the mammalian and insect brain diffusion barriers
Weiler, A., Volkenhoff, A., Hertenstein, H., & Schirmeier, S. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.008 · Cited by 46
Postnatal development of the astrocyte perivascular MLC1/GlialCAM complex defines a temporal window for the gliovascular unit maturation
Gilbert, A., Elorza‐Vidal, X., Estévez, R., Cohen‐Salmon, M., & Boulay, A.-C. (2019) · Brain Structure and Function · doi:10.1007/s00429-019-01832-w · Cited by 43
Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy
Rawat, C., Kutum, R., Kukal, S., Srivastava, A., Dahiya, U. R., Kushwaha, S. S., Sharma, S., Dash, D., Saso, L., Srivastava, A. K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-59259-x · Cited by 41
Blood-Brain Barrier and Breast Cancer Resistance Protein: A Limit to the Therapy of CNS Tumors and Neurodegenerative Diseases
Iorio, A. L., Ros, M. D., Fantappiè, O., Lucchesi, M., Facchini, L., Stival, A., Becciani, S., Guidi, M., Favre, C., de Martino, M., et al. (2016) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520616666151120121928 · Cited by 40
MAGP2 controls Notch via interactions with RGD binding integrins: Identification of a novel ECM–integrin–Notch signaling axis
DeFord, P., Brown, K., Richards, R. L., King, A., Newburn, K., Westover, K., & Albig, A. R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.011 · Cited by 39
A comprehensive review of nano drug delivery system in the treatment of CNS disorders
Spandana, K. M. A., Bhaskaran, M., Karri, V. V. S. N. R., & Natarajan, J. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101628 · Cited by 41
Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood–Brain Barrier Disruption
Pinkiewicz, M., Pinkiewicz, M., Walecki, J. M., Zaczyński, A., & Zawadzki, M. (2024) · Cancers · doi:10.3390/cancers16010236 · Cited by 38
Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and Monkeys
Iwasaki, S., Yamamoto, S., Sano, N., Tohyama, K., Kosugi, Y., Furuta, A., Hamada, T., Igari, T., Fujioka, Y., Hirabayashi, H., et al. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2613-8 · Cited by 37
Solving the Blood-Brain Barrier Challenge for the Effective Treatment of HIV Replication in the Central Nervous System
Bertrand, L., Nair, M., & Toborek, M. J. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160726113001 · Cited by 37
Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP)
Engdahl, E., van Schijndel, M. D. M., Voulgaris, D., Criscio, M. D., Ramsbottom, K. A., Rigden, D. J., Herland, A., & Rüegg, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115534 · Cited by 36
Construction and Functional Evaluation of a Three-Dimensional Blood–Brain Barrier Model Equipped With Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells
Kurosawa, T., Sako, D., Tega, Y., Debori, Y., Tomihara, Y., Aoyama, K., Kubo, Y., Amano, N., & Deguchi, Y. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03249-3 · Cited by 36
Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients
van Vliet, E. A., Iyer, A. M., Mesarosova, L., Çolakoğlu, H., Anink, J. J., van Tellingen, O., Maragakis, N. J., Shefner, J. M., Bunt, T., & Aronica, E. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz142 · Cited by 33
Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma
Sewing, A. C. P., Lagerweij, T., van Vuurden, D. G., Meel, M. H., Veringa, S. J. E., Carcaboso, A. M., Gaillard, P. J., Vandertop, W. P., Wesseling, P., Noske, D. P., et al. (2017) · Journal of Neurosurgery Pediatrics · doi:10.3171/2016.9.peds16152 · Cited by 33
Computational Modeling of Pharmaceuticals with an Emphasis on Crossing the Blood–Brain Barrier
Alves, P. A., Camargo, L. C., de Souza, G. M., Mortari, M. R., & Homem-de-Mello, M. (2025) · Pharmaceuticals · doi:10.3390/ph18020217 · Cited by 35
Relational graph convolutional networks for predicting blood–brain barrier penetration of drug molecules
Ding, Y., Jiang, X., & Kim, Y. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac211 · Cited by 32
The constitutive androstane receptor and pregnane X receptor in the brain
Torres‐Vergara, P., Ho, Y. S., Espinoza, F., Nualart, F., Escudero, C., & Penny, J. I. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15055 · Cited by 32
HMGB1 promoted P-glycoprotein at the blood-brain barrier in MCAO rats via TLR4/NF-κB signaling pathway
Wang, F., Ji, S., Wang, M., Liu, L., Li, Q., Jiang, F., Cen, J., & Ji, B. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173189 · Cited by 31
Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier
Omidi, Y., Kianinejad, N., Kwon, Y. M., & Omidian, H. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1887729 · Cited by 35
Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl- d -aspartate (NMDA) Receptor Antagonist
Gynther, M., Silvestri, I. P., Hansen, J. C., Hansen, K. B., Malm, T., Ishchenko, Y., Larsen, Y., Han, L., Kayser, S., Auriola, S. O. K., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01624 · Cited by 31
Beneficial Effects of Cannabis on Blood–Brain Barrier Function in Human Immunodeficiency Virus
Ellis, R. J., Peterson, S. N., Cherner, M., Morgan, E. E., Schrier, R. D., Tang, B., Hoenigl, M., Letendre, S. L., & Iudicello, J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa437 · Cited by 30
Protection against stroke-induced blood-brain barrier disruption by Guanxinning injection and its active-component combination via TLR4/NF-κB/MMP9-mediated neuroinflammation
Fan, S., Du, H., Yao, Y., Wang, H., Zhang, M., Shi, X.-L., Yan, J., Li, P., Xiao, G., He, S., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157162 · Cited by 29
The senses of the choroid plexus
Santos, C. R. A., Duarte, A. C., Costa, A. R., Tomás, J., Quintela, T., & Gonçalves, I. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101680 · Cited by 30
Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives
Wang, X., Wu, C., Liu, S., & Peng, D. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2069881 · Cited by 31
Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers
Liang, R., Wu, C., Liu, S., & Zhao, W. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2075986 · Cited by 29
Transporters as Drug Targets in Neurological Diseases
Qosa, H., Mohamed, L., Alqahtani, S., Abuasal, B., Hill, R., & Kaddoumi, A. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.435 · Cited by 31
Self-citation
Brown rats on farmland
Macdonald, D. W., Berdoy, M., & Webster, J. P. (2015) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198745501.003.0011 · Cited by 27
Co-Culture Models: Key Players in In Vitro Neurotoxicity, Neurodegeneration and BBB Modeling Studies
Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. (2024) · Biomedicines · doi:10.3390/biomedicines12030626 · Cited by 27
Physicochemical properties of engineered nanomaterials that influence their nervous system distribution and effects
Yokel, R. A. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.05.007 · Cited by 27
Physical associations of microglia and the vascular blood-brain barrier and their importance in development, health, and disease
Knopp, R. C., Banks, W. A., & Erickson, M. A. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102648 · Cited by 27
Noncovalent Strategy with Cell-Penetrating Peptides to Facilitate the Brain Delivery of Insulin through the Blood–Brain Barrier
Kamei, N., Yamaoka, A., Fukuyama, Y., Itokazu, R., & Takeda‐Morishita, M. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00848 · Cited by 27
Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery
Mohi-ud-din, R., Mir, R. H., Mir, P. A., Banday, N., Shah, A. J., Sawhney, G., Bhat, M. M., Batiha, G. E., & Pottoo, F. H. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220817115003 · Cited by 26
Novel Phenobarbital-Loaded Nanostructured Lipid Carriers for Epilepsy Treatment: From QbD to In Vivo Evaluation
Montoto, S. S., Sbaraglini, M. L., Cisneros, J. S., Chain, C. Y., Ferretti, V., León, I. E., Álvarez, V. A., Castro, G. R., Islan, G. A., Talevi, A., et al. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.908386 · Cited by 28
Differential Expression of ABC Transporter Genes in Brain Vessels vs. Peripheral Tissues and Vessels from Human, Mouse and Rat
Zhang, W., Liu, Q. Y., Haqqani, A. S., Liu, Z., Sodja, C., Leclerc, S., Baumann, E., Delaney, C. E., Brunette, E., & Stanimirovic, D. B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051563 · Cited by 28

Authors: Qosa, H., Miller, D. S., Pasinelli, P., & Trotti, D.
Affiliations: Thomas Jefferson University (US)
National Institutes of Health (US)
Corresponding author: Qosa, Hisham
Trotti, Davide
ORCID: Qosa, Hisham
Pasinelli, Piera
Trotti, Davide
Venue: Brain Research
Publisher: Elsevier BV
Published: 2015-12
Volume: 1628
Issue: Pt B
Pages: 298-316
ISSN: 0006-8993 (ISSN-L)
DOI: 10.1016/j.brainres.2015.07.005
PMC: PMC4681613
OpenAlex: W908901015
Cited by: 249
References: 215
Citations by year: 2026: 17 · 2025: 15 · 2024: 19 · 2023: 27 · 2022: 26 · 2021: 30 · 2020: 27 · 2019: 23 · 2018: 22 · 2017: 18 · 2016: 23 · 2015: 1
FWCI: 2.29
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Health (RO1-NS074886)
Intramural Research program NIH/NIEHS
Topics: Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords: ABC transporters, blood-brain barrier, P-glycoprotein, ABCG2, MRP1, MRP2, efflux pumps, transporter regulation, tight junctions, neurological disorders, neuroprotection, signaling pathways, brain capillary endothelium
MeSH terms: Animals, Blood-Brain Barrier, Humans, Nervous System Diseases, ATP-Binding Cassette Transporters

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks